Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Breast Cancer

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Taxane followed by anthracyclines vs anthracyclines followed by taxane

Treatment adherence (defined as dose reduction) ( · neoadjuvant therapy for early breast cancer

Taxane followed by anthracyclines showed no clear difference in treatment adherence (defined as dose reduction) ( compared with anthracyclines followed by taxane (moderate certainty).

1 finding from 1 review

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer 2019 · Cochrane Headline outcomes only
RR 0.81 [0.59, 1.11]
1 study · 280 participants
Moderate

Taxane followed by anthracyclines vs anthracyclines followed by taxane

Treatment adherence (defined as dose delay) ( · adjuvant therapy for early breast cancer

Taxane followed by anthracyclines showed no clear difference in treatment adherence (defined as dose delay) ( compared with anthracyclines followed by taxane (moderate certainty).

1 finding from 1 review

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer 2019 · Cochrane Headline outcomes only
RR 0.76 [0.52, 1.12]
3 studies · 238 participants
Moderate